# BTIG Research

Type: Company

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/btig-research
Canonical HTML page: https://getfinancebrief.com/entity/btig-research

## Timeline

- **2026-03-05**: Q4 Earnings Release — Guidewire reports Q4 CY2025 sales topping estimates, triggering a sentiment shift.
- **2026-02-26**: Analyst Downgrade — BTIG Research cuts price target to $175, citing software sector headwinds.
- **2026-02-24**: Insider Selling Activity — CEO Mike Rosenbaum sells 1,200 shares as stock reaches a 1-year low.
- **2026-02-18**: Sompo Group Expansion — Guidewire wins long-term deal to modernize Sompo's worldwide operations via Guidewire Cloud.

## Recent coverage (2 stories)

### Wall Street Zen Slaps Sell Ratings on CME, Novavax, and SNDL – 3 Stocks to Watch
2026-08-04 12:11:28 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

In a single day, Wall Street Zen downgraded CME Group to strong sell, and Novavax and SNDL to sell, sending bearish signals across exchanges, biotech, and cannabis. Markets digest the calls amid wide analyst disagreement.
Full story: https://getfinancebrief.com/story/wall-street-zen-downgrades-cme-nvax-sndl-finance

### Guidewire Software Surges as Q4 Sales Beat Estimates, Defying Sector Headwinds
2026-03-05 23:29:56 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Guidewire Software reported Q4 CY2025 sales that topped analyst estimates, providing a strong rebuttal to recent analyst downgrades and insider selling concerns. The results highlight the accelerating adoption of Guidewire Cloud, bolstered by major international deals like the Sompo Group expansion.
Full story: https://getfinancebrief.com/story/guidewire-software-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.